ADMA Class Alert: ADMA Biologics Misrepresentations about Channel Stuffing Under Review in Securities Fraud Class Action – Contact BFA Law if You Lost Money

A securities fraud class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ:ADMA) and certain of the Company’s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/adma-biologics-class-action-lawsuit . Key Details of the ADMA ($ADMA) Class Action: Lead Plaintiff Deadline: August 10, 2026 Alleged Misconduct: Securities fraud relating to allegations that ADMA’s reported 20% growth for 2025 was driven by a channel stuffing scheme Largest Stock Drop: March 24, 2026 – 16.6% Stock Drop Court: U.S. District Court for the District of New Jersey Action: Contact BFA Law to discuss your rights Investors have until August 10, 2026, to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in ADMA securities. The class action is pending in the U.S. District Court for the District of New Jersey. It is captioned Mazzarino v. ADMA Biologics, Inc., et al. , No. 26-cv-6918. Why is ADMA Biologics Being Sued for Securities Fraud? ADMA has been sued for securities fraud following significant stock drop...